CIK 0001761918 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Erasca, Inc.
Sign in to watch- Ticker
- ERAS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831217027
- Phone
- (858) 465-6511
- Business address
- 3115 MERRYFIELD ROW, THIRD FLOOR, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 10 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-22 | LIU JEAN I Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2023-06-22 | Start Valerie Denise Harding Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2023-06-22 | Hambleton Julie Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2023-06-22 | Casdin Alexander W. Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2023-06-22 | Bristol James Arthur Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2023-06-22 | Chen Bihua Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2023-06-08 | Lim Jonathan E Chairman & CEO | Purchase | +100,000 | $2.75 | $275K | 18,396,216 |
| 2023-04-10 | Morris Shannon Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +375,000 | 375,000 | ||
| 2023-04-10 | Casdin Alexander W. Director | Purchase | +20,000 | $2.76 | $55K | 463,974 |
| 2023-03-28 | Lim Jonathan E Chairman & CEO | Purchase | +100,000 | $2.84 | $284K | 18,296,216 |
| 2023-02-01 | Lim Jonathan E Chairman & CEO | Grant or award · Stock Option (right to buy) | +1,500,000 | 1,500,000 | ||
| 2023-02-01 | Chacko David M. Chief Financial Officer | Other acquisition | +1,748 | $4.10 | $7K | 239,248 |
| 2023-02-01 | Chacko David M. Chief Financial Officer | Other acquisition | +2 | $3.89 | $8 | 239,248 |
| 2023-02-01 | Chacko David M. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2023-02-01 | Wei Lin Chief Medical Officer | Other acquisition | +1,748 | $4.10 | $7K | 315,812 |
| 2023-02-01 | Wei Lin Chief Medical Officer | Other acquisition | +2 | $3.89 | $8 | 315,812 |
| 2023-02-01 | Wei Lin Chief Medical Officer | Grant or award · Stock Option (right to buy) | +560,000 | 560,000 | ||
| 2023-02-01 | Garner Ebun General Counsel & Corp. Sec. | Other acquisition | +2,388 | $4.10 | $10K | 4,280 |
| 2023-02-01 | Garner Ebun General Counsel & Corp. Sec. | Other acquisition | +2 | $3.89 | $8 | 4,280 |
| 2023-02-01 | Garner Ebun General Counsel & Corp. Sec. | Grant or award · Stock Option (right to buy) | +480,000 | 480,000 |
Page 5 of 7 · 121 trades